Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline Performance Share Plan ("PSP") notified the Company and the under-mentioned persons on 12 April 2011 of an increase in their notional interests in Ordinary shares and ADRs following the notional re-investment of the dividend paid to shareholders on 7 April 2011.
Following the three year measurement period and subsequent release of the proportion of the participants' PSP award vesting in February 2011, the Administrators of the PSP notified the Company and the under-mentioned persons on 26 April 2011 of the vesting and release of the following Ordinary shares and ADRs as a result of the dividend paid to shareholders on 7 April 2011, in proportion to the relevant three year measurement period.
|
Percentage of PSP awards vested |
Vested Ordinary shares |
Vested ADRs |
Mr A P Witty |
35.0% |
1785 |
|
Dr M M Slaoui |
35.0% |
|
427 |
Mr S M Bicknell |
17.5% |
28 |
|
Mr J M Clarke |
35.0% |
|
480 |
Mr M Dunoyer |
35.0% |
181 |
|
Mr E J Gray |
35.0% |
312 |
|
Mr S A Hussain |
35.0% |
277 |
|
Mr W C Louv |
35.0% |
|
155 |
Dr D Pulman |
35.0% |
|
155 |
Mr D S Redfern |
17.5% |
37 |
|
Mr J R Stéphenne |
17.5% |
83 |
|
Ms C Thomas |
17.5% |
28 |
|
Mr D E Troy |
35.0% |
|
345 |
Dr P J T Vallance |
17.5% |
115 |
|
Mrs V A Whyte |
17.5% |
7 |
|
This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a).
V A Whyte
Company Secretary
26 April 2011